{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:08:18Z","timestamp":1792872498366,"version":"4.5.0"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005992","name":"Ministry of Education, Science and Culture","doi-asserted-by":"crossref","award":["15K08081"],"award-info":[{"award-number":["15K08081"]}],"id":[{"id":"10.13039\/501100005992","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Project for Practice Development of National TCM Clinical Research Bases","award":["JDZX2015194"],"award-info":[{"award-number":["JDZX2015194"]}]},{"name":"Japan China Sasakawa Medical Fellowship","award":["2017816"],"award-info":[{"award-number":["2017816"]}]},{"name":"State Scholarship Fund of China Scholarship Council","award":["201808420024"],"award-info":[{"award-number":["201808420024"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pharmthera.2020.107659","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T11:42:03Z","timestamp":1597232523000},"page":"107659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases"],"prefix":"10.1016","volume":"217","author":[{"given":"Wencheng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Onda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107659_bb0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0162-3109(00)00186-7","article-title":"Immunosuppressive drugs: The first 50 years and a glance forward","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0010","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","article-title":"P-glycoprotein: From genomics to mechanism","volume":"22","author":"Ambudkar","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and activation of NF-\u03baB in the immune system","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0020","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1016\/S0960-9822(06)00046-7","article-title":"Apoptosis: Activate NF-\u03baB or die?","volume":"7","author":"Baichwal","year":"1997","journal-title":"Current Biology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0025","doi-asserted-by":"crossref","first-page":"152956","DOI":"10.1016\/j.phymed.2019.152956","article-title":"Cepharanthine: An update of its mode of action, pharmacological properties and medical applications","volume":"62","author":"Bailly","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/tri.12553","article-title":"The need for minimization strategies: Current problems of immunosuppression","volume":"28","author":"Bamoulid","year":"2015","journal-title":"Transplant International"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nri.2017.99","article-title":"The spectrum of T cell metabolism in health and disease","volume":"18","author":"Bantug","year":"2018","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0040","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0045","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1081\/IMM-120030732","article-title":"The interleukin (IL)-2 family cytokines: Survival and proliferation signaling pathways in T lymphocytes","volume":"33","author":"Benczik","year":"2004","journal-title":"Immunological Investigations"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine--a molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0060","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood-2006-12-060970","article-title":"Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway","volume":"110","author":"Bornhauser","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12026-011-8216-z","article-title":"Regulation of NF-\u03baB induction by TCR\/CD28","volume":"50","author":"Cheng","year":"2011","journal-title":"Immunologic Research"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0075","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/s41375-018-0065-5","article-title":"An \u201coff-the-shelf\u201d fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies","volume":"32","author":"Cooper","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0080","doi-asserted-by":"crossref","first-page":"101097","DOI":"10.1016\/j.beha.2019.101097","article-title":"Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies","volume":"32","author":"Cooper","year":"2019","journal-title":"Best Practice & Research. Clinical Haematology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0085","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V87.3.1140.bloodjournal8731140","article-title":"Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia","volume":"87","author":"Coustan-Smith","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0090","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.taap.2012.03.008","article-title":"Oral and inhaled corticosteroids: Differences in P-glycoprotein (ABCB1) mediated efflux","volume":"260","author":"Crowe","year":"2012","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0095","doi-asserted-by":"crossref","first-page":"28420","DOI":"10.1074\/jbc.M109.012674","article-title":"Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice","volume":"284","author":"Cui","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0100","doi-asserted-by":"crossref","first-page":"100591","DOI":"10.1016\/j.blre.2019.100591","article-title":"Targeting steroid resistance in T-cell acute lymphoblastic leukemia","volume":"38","author":"De Smedt","year":"2019","journal-title":"Blood Reviews"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-4274(99)00252-0","article-title":"Activation of apoptosis pathways by anticancer treatment","volume":"112-113","author":"Debatin","year":"2000","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1389201023378265","article-title":"Modulating poly (ADP-ribose) polymerase activity: Potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress","volume":"3","author":"Decker","year":"2002","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrm2393","article-title":"Expansion and evolution of cell death programmes","volume":"9","author":"Degterev","year":"2008","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0120","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s10495-019-01548-6","article-title":"Berberine mitigates IL-21\/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17\/Treg imbalance in rheumatoid arthritis","volume":"24","author":"Dinesh","year":"2019","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0135","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.4049\/jimmunol.181.11.7617","article-title":"The Erk2 MAPK regulates CD8 T cell proliferation and survival","volume":"181","author":"D\u2019Souza","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exphem.2015.05.017","article-title":"Novel biological insights in T-cell acute lymphoblastic leukemia","volume":"43","author":"Durinck","year":"2015","journal-title":"Experimental Hematology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10753-013-9744-6","article-title":"Cepharanthine attenuates lipopolysaccharide-induced mice mastitis by suppressing the NF-\u03baB signaling pathway","volume":"37","author":"Ershun","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/1568009616666151106120434","article-title":"Targeting ABCB1 and ABCC1 with their specific inhibitor CBT-1(R) can overcome drug resistance in osteosarcoma","volume":"16","author":"Fanelli","year":"2016","journal-title":"Current Cancer Drug Targets"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0155","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.lfs.2006.12.001","article-title":"The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: Implications for cancer, shock, and inflammatory diseases","volume":"80","author":"Furusawa","year":"2007","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF01757343","article-title":"High expression of BCL-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis","volume":"69","author":"Gala","year":"1994","journal-title":"Annals of Hematology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0165","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.autrev.2015.02.006","article-title":"P-glycoprotein in autoimmune rheumatic diseases","volume":"14","author":"Garcia-Carrasco","year":"2015","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0170","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1096\/fasebj.6.7.1563596","article-title":"Apoptosis: A different type of cell death","volume":"6","author":"Gerschenson","year":"1992","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0175","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-\u03baB: Players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11101-013-9293-5","article-title":"Plant derived inhibitors of NF-\u03baB","volume":"13","author":"Golan-Goldhirsh","year":"2014","journal-title":"Phytochemistry Reviews"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1615\/CritRevEukarGeneExpr.v9.i3-4.130","article-title":"The nuclear lamina: Molecular organization and interaction with chromatin","volume":"9","author":"Goldberg","year":"1999","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002208","article-title":"Overcoming steroid resistance in T cell acute lymphoblastic leukemia","volume":"13","author":"Goossens","year":"2016","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/jsbi.2000.4216","article-title":"Review: Nuclear lamins--structural proteins with fundamental functions","volume":"129","author":"Gruenbaum","year":"2000","journal-title":"Journal of Structural Biology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.phymed.2016.01.001","article-title":"Comparative cytotoxicity of chelidonine and homochelidonine, the dimethoxy analogues isolated from Chelidonium majus L. (Papaveraceae), against human leukemic and lung carcinoma cells","volume":"23","author":"Havelek","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0210","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1093\/emboj\/16.15.4698","article-title":"I\u03baB\u03b1-independent downregulation of NF-\u03baB activity by glucocorticoid receptor","volume":"16","author":"Heck","year":"1997","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","article-title":"Glucocorticoids in T cell apoptosis and function","volume":"63","author":"Herold","year":"2006","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-3565(25)12084-3","article-title":"Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein","volume":"275","author":"Hirai","year":"1995","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.intimp.2006.09.020","article-title":"Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine","volume":"7","author":"Hirano","year":"2007","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0014-2999(98)00941-8","article-title":"Plant alkaloid tetrandrine downregulates protein kinase C-dependent signaling pathway in T cells","volume":"367","author":"Ho","year":"1999","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0235","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bjp.0706000","article-title":"Plant alkaloid tetrandrine downregulates I\u03baB\u03b1 kinases-I\u03baB\u03b1-NF-\u03baB signaling pathway in human peripheral blood T cell","volume":"143","author":"Ho","year":"2004","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneph.2016.18","article-title":"Biologics for the treatment of autoimmune renal diseases","volume":"12","author":"Holdsworth","year":"2016","journal-title":"Nature Reviews. Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0245","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.anclin.2017.04.001","article-title":"Overview of immunosuppressive therapy in solid organ transplantation","volume":"35","author":"Holt","year":"2017","journal-title":"Anesthesiology Clinics"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0250","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.intimp.2018.11.020","article-title":"Inhibitory effect of berberine on interleukin-2 secretion from PHA-treated lymphocytic Jurkat cells","volume":"66","author":"Hu","year":"2019","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10753-013-9734-8","article-title":"Cepharanthine, an alkaloid from Stephania cepharantha Hayata, inhibits the inflammatory response in the RAW264.7 cell and mouse models","volume":"37","author":"Huang","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0260","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/10428194.2017.1335397","article-title":"Continuing challenges and current issues in acute lymphoblastic leukemia","volume":"59","author":"Kansagra","year":"2018","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0265","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood.V91.3.991","article-title":"Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse","volume":"91","author":"Kaufmann","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0270","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0192-0561(92)90053-N","article-title":"Selective inhibition of T-cell-dependent immune responses by bisbenzylisoquinoline alkaloids in vivo","volume":"14","author":"Kondo","year":"1992","journal-title":"International Journal of Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0275","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri2115","article-title":"Life and death in peripheral T cells","volume":"7","author":"Krammer","year":"2007","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jss.2010.01.007","article-title":"Cepharanthine exerts anti-inflammatory effects via NF-\u03baB inhibition in a LPS-induced rat model of systemic inflammation","volume":"171","author":"Kudo","year":"2011","journal-title":"The Journal of Surgical Research"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0285","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cell.2009.08.021","article-title":"Caspases and kinases in a death grip","volume":"138","author":"Kurokawa","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0290","first-page":"1093","article-title":"Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases","volume":"23","author":"Lai","year":"2002","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0295","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/00007890-199911150-00027","article-title":"Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: Potential immunosuppressants in transplantation immunology","volume":"68","author":"Lai","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0300","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.4049\/jimmunol.166.11.6914","article-title":"Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas\/Fas ligand interaction","volume":"166","author":"Lai","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcell.2019.00023","article-title":"Immunomodulatory roles of cell cycle regulators","volume":"7","author":"Laphanuwat","year":"2019","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0310","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1201-1291","article-title":"Possible new role for NF-\u03baB in the resolution of inflammation","volume":"7","author":"Lawrence","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0315","first-page":"281651","article-title":"Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo","volume":"2011","author":"Li","year":"2011","journal-title":"Journal of Biomedicine & Biotechnology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0320","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1211\/0022357022115","article-title":"Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells","volume":"55","author":"Liu","year":"2003","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0325","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1189\/jlb.0106056","article-title":"(S)-armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLCgamma activation in a PI-3K-dependent manner","volume":"81","author":"Liu","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0330","doi-asserted-by":"crossref","first-page":"40800","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00280-001-0411-5","article-title":"Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA","volume":"49","author":"Liu","year":"2002","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0340","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ptr.5866","article-title":"Synergistic effect of TPD7 and berberine against leukemia Jurkat cell growth through regulating Ephrin-B2 signaling","volume":"31","author":"Ma","year":"2017","journal-title":"Phytotherapy Research"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0345","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00007890-199702270-00017","article-title":"Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy","volume":"63","author":"Migita","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0350","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/00007890-199910150-00020","article-title":"FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL","volume":"68","author":"Migita","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0355","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopha.2017.10.116","article-title":"Tetrandrine and cancer - an overview on the molecular approach","volume":"97","author":"Bhagya","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0360","first-page":"635","article-title":"Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma","volume":"24","author":"Nakajima","year":"2004","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0365","doi-asserted-by":"crossref","first-page":"14681","DOI":"10.1073\/pnas.95.25.14681","article-title":"Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria","volume":"95","author":"Narita","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0370","author":"NCCN"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0375","doi-asserted-by":"crossref","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","article-title":"Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant","volume":"273","author":"Oliver","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0380","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0385","first-page":"166","article-title":"Treatment of relapsed\/refractory acute lymphoblastic leukemia","volume":"17","author":"Paul","year":"2019","journal-title":"Clinical Advances in Hematology & Oncology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0390","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.phrs.2018.02.031","article-title":"Personalized immunosuppression in elderly renal transplant recipients","volume":"130","author":"Peeters","year":"2018","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0395","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0400","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1042819021000040288","article-title":"High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children","volume":"44","author":"Plasschaert","year":"2003","journal-title":"Leukemia & Lymphoma"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0405","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0410","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.bcp.2007.12.001","article-title":"Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))","volume":"75","author":"Robey","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0415","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1734-1140(11)70500-X","article-title":"Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions","volume":"63","author":"Rogosnitzky","year":"2011","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0420","first-page":"173","article-title":"High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura","volume":"51","author":"Saito","year":"1996","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0425","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccr.2012.09.016","article-title":"Therapeutic targeting of the cyclin D3:CDK4\/6 complex in T cell leukemia","volume":"22","author":"Sawai","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0430","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nature Reviews. Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0435","doi-asserted-by":"crossref","first-page":"a008714","DOI":"10.1101\/cshperspect.a008714","article-title":"Mechanisms of action of Bcl-2 family proteins","volume":"5","author":"Shamas-Din","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0163-7258(01)00164-4","article-title":"Apoptosis: The quiet death silences the immune system","volume":"92","author":"Sun","year":"2001","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0445","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.phymed.2014.04.029","article-title":"Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells","volume":"21","author":"Sun","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0450","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-09-4230","article-title":"Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway","volume":"70","author":"Sung","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0455","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/1087057109359422","article-title":"Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay","volume":"15","author":"Susa","year":"2010","journal-title":"Journal of Biomolecular Screening"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0460","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.intimp.2012.04.015","article-title":"Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma","volume":"13","author":"Tabata","year":"2012","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0465","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.intimp.2016.02.025","article-title":"Natural product derived immune-regulatory agents","volume":"37","author":"Talmadge","year":"2016","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0470","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","article-title":"The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Proliferation"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0475","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10753-016-0472-6","article-title":"Berberine attenuates inflammation associated with delayed-type hypersensitivity via suppressing Th1 response and inhibiting apoptosis","volume":"40","author":"Wang","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0480","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1248\/bpb.28.1979","article-title":"Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells","volume":"28","author":"Wang","year":"2005","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0485","first-page":"461","article-title":"Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7\/DOX) cells","volume":"43","author":"Wang","year":"2008","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0490","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0495","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.08570814","article-title":"Immunosuppressive medications","volume":"11","author":"Wiseman","year":"2016","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0500","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0898-6568(01)00278-9","article-title":"Modes of activation of mitogen-activated protein kinases and their roles in cepharanthine-induced apoptosis in human leukemia cells","volume":"14","author":"Wu","year":"2002","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jcb.1155","article-title":"Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines","volume":"82","author":"Wu","year":"2001","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0510","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pharmthera.2010.01.007","article-title":"Personalized immunosuppressive therapy in pediatric heart transplantation: Progress, pitfalls and promises","volume":"126","author":"Xie","year":"2010","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0515","doi-asserted-by":"crossref","first-page":"115553","DOI":"10.1016\/j.bmc.2020.115553","article-title":"Bisbenzylisoquinoline alkaloids and P-glycoprotein function: A structure activity relationship study","volume":"28","author":"Xu","year":"2020","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0520","article-title":"Absolute configuration of tetrandrine and isotetrandrine influences their anti-proliferation effects in human T cells via different regulation of NF-\u03baB","volume":"76","author":"Xu","year":"2021","journal-title":"Z Naturforsch C J Biosci"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0525","doi-asserted-by":"crossref","unstructured":"Xu, X., Lai, Y., & Hua, Z. C. (2019). Apoptosis and apoptotic body: Disease message and therapeutic target potentials. Biosci. Rep., 39 2019, (bsr20180992).","DOI":"10.1042\/BSR20180992"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0530","first-page":"295","article-title":"Inhibitory effects of berberine on the activation and cell cycle progression of human peripheral lymphocytes","volume":"2","author":"Xu","year":"2005","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0535","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/1440-1681.12797","article-title":"Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients","volume":"44","author":"Xu","year":"2017","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0540","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2017.04.007","article-title":"Tetrandrine potentiates the glucocorticoid pharmacodynamics via inhibiting P-glycoprotein and mitogen-activated protein kinase in mitogen-activated human peripheral blood mononuclear cells","volume":"807","author":"Xu","year":"2017","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0545","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.leukres.2005.08.005","article-title":"Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia","volume":"30","author":"Xu","year":"2006","journal-title":"Leukemia Research"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0550","doi-asserted-by":"crossref","first-page":"173232","DOI":"10.1016\/j.ejphar.2020.173232","article-title":"Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cells","volume":"881","author":"Xu","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0555","doi-asserted-by":"crossref","first-page":"108726","DOI":"10.1016\/j.cbi.2019.108726","article-title":"Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K\/Akt\/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells","volume":"310","author":"Xu","year":"2019","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0560","first-page":"77","article-title":"Role of nuclear lamins in nuclear segmentation of human neutrophils","volume":"31","author":"Yabuki","year":"1999","journal-title":"Physiological Chemistry and Physics and Medical NMR"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0565","article-title":"The role of the JAK-STAT pathway and related signal cascades in telomerase activation during the development of hematologic malignancies","volume":"2","author":"Yamada","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0570","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1038\/sj.onc.1204984","article-title":"The protein kinase PKB\/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change","volume":"20","author":"Yamaguchi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0575","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/ped.13151","article-title":"High-dose Cepharanthin for pediatric chronic immune thrombocytopenia in Japan","volume":"59","author":"Yamazaki","year":"2017","journal-title":"Pediatrics International"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0580","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jchromb.2017.10.048","article-title":"An UPLC-MS\/MS method for quantifying tetrandrine and its metabolite berbamine in human blood: Application to a human pharmacokinetic study","volume":"1070","author":"Yang","year":"2017","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.06.001","article-title":"Antibody therapeutics and immunoregulation in cancer and autoimmune disease","volume":"64","author":"Yasunaga","year":"2020","journal-title":"Seminars in Cancer Biology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0590","first-page":"65","article-title":"On the role of hydroxyl radical and the effect of tetrandrine on nuclear factor--kappaB activation by phorbol 12-myristate 13-acetate","volume":"30","author":"Ye","year":"2000","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0595","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/cas.13792","article-title":"Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis","volume":"109","author":"Yogosawa","year":"2018","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0600","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1349-7006.2009.01488.x","article-title":"The cell death machinery governed by the p53 tumor suppressor in response to DNA damage","volume":"101","author":"Yoshida","year":"2010","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0605","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13046-018-0779-2","article-title":"Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy","volume":"37","author":"Yu","year":"2018","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0610","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/jcmm.13141","article-title":"Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation","volume":"21","author":"Yuan","year":"2017","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0615","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bcp.2015.11.025","article-title":"Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor","volume":"101","author":"Yuan","year":"2016","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0620","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.intimp.2019.01.040","article-title":"Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells","volume":"69","author":"Zou","year":"2019","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107659_bb0625","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3324\/haematol.2011.059030","article-title":"The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia","volume":"97","author":"Zuurbier","year":"2012","journal-title":"Haematologica"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:10:24Z","timestamp":1759011024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820301893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":125,"alternative-id":["S0163725820301893"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107659","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107659"}}